Welcome: A Research-Focused Look at the Peptide Landscape

It should go without saying that peptide research has moved well beyond the confines of obscure laboratory journals.

Today, peptides are being studied across a remarkably broad range of areas, including weight loss and metabolism, inflammation, tissue repair, endocrinology, neurological disease, immune function, aging, and body composition. At the same time, an increasingly large community of people is experimenting with compounds that may be years ahead of formal approval, years behind it, or never intended to become conventional medicines at all.

That creates an unusual information problem: scientific papers can tell us what researchers have observed under controlled conditions. Clinical trial registries can tell us what investigators are studying next. Regulatory documents can tell us what has been formally established. Meanwhile, online communities provide an entirely different kind of information: what people are actually doing outside those systems. Those sources are not interchangeable. But this site exists to examine all of them.

Our goal is not to tell readers what peptides they should take, how much they should use, or what protocol they should follow. Instead, we want to document the current landscape as accurately as possible.

That means looking at questions such as:
- What is a particular peptide, and what does it actually do?
- What evidence exists in humans, animals, or laboratory models?
- What clinical trials have been completed, and what trials are still underway?
- What areas of research appear especially promising?
- How are compounds currently being used within peptide and research communities?
- Where did commonly discussed protocols originate?
- Which claims have reasonable scientific support, and which have gradually become accepted online despite weak evidence?
- Where are researchers, clinicians, and self-directed communities interpreting the same evidence differently?

(We find the last question is particularly interesting.)

Real-world peptide use frequently develops faster than the research literature surrounding it. A compound may accumulate years of community experience while having remarkably little published human data. In other cases, a peptide may have substantial scientific literature behind it but very little interest outside academic research. We think both situations deserve examination.

When we discuss community practices, we will report them as community practices. Describing how people currently use a compound does not mean endorsing that practice. Likewise, when we describe the protocol used in a clinical trial, that does not mean the trial protocol should be copied outside the study.

We will also try to distinguish clearly between different levels of evidence:
- A mechanism that makes biological sense is interesting, but it is not the same thing as demonstrated clinical benefit.
- An animal study can be important without proving that the same result occurs in humans.
- A small human trial can be encouraging without providing a definitive answer.
- And widespread anecdotal use can reveal useful patterns while still being vulnerable to the placebo effect, selection bias, inconsistent products, incomplete reporting, and countless other confounding factors.

Peptides sit at an unusually interesting intersection of established medicine, experimental therapeutics, biotechnology, longevity research, performance culture, and citizen science. There is a lot happening in that intersection. Our intention is to watch it carefully, follow the evidence wherever it leads, and provide readers with a clearer picture of what researchers and peptide communities are actually doing today.

So welcome to the project. Welcome to PepBuddies Health & Wellness.

\ Get the latest news /